Kintara Therapeutics, Inc. reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported net loss was USD 2.96 million compared to USD 4.6 million a year ago. Basic loss per share from continuing operations was USD 1.83 compared to USD 3.39 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1488 USD | -5.82% | +22.57% | -12.26% |
Apr. 03 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Apr. 03 | Sector Update: Health Care | MT |
1st Jan change | Capi. | |
---|---|---|
-12.26% | 8.23M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KTRA Stock
- News Kintara Therapeutics, Inc.
- Kintara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023